Tolan, the AI companion designed to help people manage their daily lives, navigate relationships and emotions, and accomplish their goals, has just expanded its runway with another $30 million in capital.
Gilead Sciences has helped bolster the appeal of Vir Biotechnology’s T cell engager technology with a new licensing deal that includes $135 million in upfront and near-term payments—including an equity stake—and could tack on an additional $1.74 billion in milestones.
Retro, the friend-focused photo-sharing app built by former Instagram product engineers Nathan Sharp and Ryan Olson, has raised north of $21 million in Series A funding, according to an SEC filing.
